AC
The Angeles Clinic and Research Institute at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
The Angeles Clinic and Research Institute brings 1 presentation to SITC 2026 in Phoenix. Its program centres on bispecific drugs that block VEGF and the PD-1 pathway at the same time. Its focus is current research on these VEGF and PD-1 bispecifics, set within a debate over whether the approach lives up to its promise.
| Organization | SITC 2026 Attendance |
|---|---|
AC The Angeles Clinic and Research Institute Los Angeles, CA | |
Oncology practice and clinical research institute in Los Angeles, affiliated with Cedars-Sinai. | Session Fri Nov 6 11:30am–12:15pm Clinical Oral Abstract Session
Session Sun Nov 8 10:45am–12:25pm COOPERATIVE BINDING: The bi-specific VEGF/PD(L)-1 Inhibitor Approach to cancer immunotherapy: Savior or Pretender?
Talk Sun Nov 8 11:45am–12:00pm |
Instantly find 20 buyers from The Angeles Clinic and Research Institute
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction